Balasa Dinverno & Foltz’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.17M | Buy |
4,029
+2,098
| +109% | +$608K | 0.07% | 110 |
|
|
2022
Q2 | $544K | Buy |
+1,931
| New | +$544K | 0.03% | 190 |
|
|
2021
Q1 | – | Sell |
-984
| Closed | -$233K | – | 314 |
|
|
2020
Q4 | $233K | Sell |
984
-1,519
| -61% | -$360K | 0.02% | 260 |
|
|
2020
Q3 | $681K | Sell |
2,503
-762
| -23% | -$207K | 0.06% | 126 |
|
|
2020
Q2 | $948K | Buy |
3,265
+1,643
| +101% | +$477K | 0.11% | 79 |
|
|
2020
Q1 | $386K | Buy |
+1,622
| New | +$386K | 0.05% | 158 |
|